Syneos Health Stock Shares Outstanding
Syneos Health fundamentals help investors to digest information that contributes to Syneos Health's financial success or failures. It also enables traders to predict the movement of Syneos Stock. The fundamental analysis module provides a way to measure Syneos Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Syneos Health stock.
Syneos |
Syneos Health Company Shares Outstanding Analysis
Syneos Health's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Syneos Health Shares Outstanding | 103.72 M |
Most of Syneos Health's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syneos Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Syneos Health has 103.72 M of shares currently outstending. This is 42.55% lower than that of the Life Sciences Tools & Services sector and 27.32% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 81.86% higher than that of the company.
Syneos Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syneos Health's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics of similar companies.Syneos Health is currently under evaluation in shares outstanding category among its peers.
Syneos Fundamentals
Return On Equity | 0.0209 | |||
Return On Asset | 0.0263 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 7.23 B | |||
Shares Outstanding | 103.72 M | |||
Shares Owned By Insiders | 0.48 % | |||
Shares Owned By Institutions | 94.74 % | |||
Number Of Shares Shorted | 6.76 M | |||
Price To Earning | 18.05 X | |||
Price To Book | 1.07 X | |||
Price To Sales | 0.66 X | |||
Revenue | 5.39 B | |||
Gross Profit | 1.25 B | |||
EBITDA | 699.99 M | |||
Net Income | 266.5 M | |||
Cash And Equivalents | 124.2 M | |||
Cash Per Share | 1.21 X | |||
Total Debt | 2.9 B | |||
Debt To Equity | 0.93 % | |||
Current Ratio | 1.10 X | |||
Book Value Per Share | 33.69 X | |||
Cash Flow From Operations | 426.98 M | |||
Short Ratio | 5.59 X | |||
Earnings Per Share | 0.70 X | |||
Price To Earnings To Growth | 1.28 X | |||
Target Price | 42.5 | |||
Number Of Employees | 28.77 K | |||
Beta | 1.58 | |||
Market Capitalization | 4.43 B | |||
Total Asset | 8.2 B | |||
Retained Earnings | 167.69 M | |||
Working Capital | 219.25 M | |||
Current Asset | 1.09 B | |||
Current Liabilities | 1.07 B | |||
Z Score | 1.92 | |||
Net Asset | 8.2 B |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |